Počet záznamov: 1
protilátky bišpecifické
SYS d018033 LBL 00000nx--j22000003--45-- 005 20240119201319.6 100 $a 19930604csloy0103----ba0 152 $b mesh 250 $a protilátky bišpecifické $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 94 $8 eng 300 1-
$a Antibodies (1985-1993) $8 eng 300 1-
$a specific Antibodies (1985-1993) $8 eng 330 1-
$a Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors. $8 eng 450 $a Bifunctional Antibodies $5 e $8 eng 450 $a Bispecific Antibodies $5 e $8 eng 550 $3 sllk_un_auth*d000918 $Y Antibody Specificity $5 B $a špecifickosť protilátková 550 $3 sllk_un_auth*d003602 $Y Cytotoxicity, Immunologic $5 B $a cytotoxicita imunologická 550 $3 sllk_un_auth*d007155 $Y Immunologic Factors $5 P $a faktory imunologické 550 $3 sllk_un_auth*d000922 $Y Immunotoxins $5 F $a imunotoxíny 550 $3 sllk_un_auth*d016499 $Y Radioimmunotherapy $5 F $a rádioimunoterapia 686 $a D12.776.124.486.485.114.125 686 $a D12.776.124.790.651.114.134 686 $a D12.776.377.715.548.114.134 750 $a Antibodies, Bispecific $8 eng 801 -0
$a US $b DNLM $c 19930604 801 -2
$a SK $b BA006 $c 19991005 820 $a do not coordinate with ANTIBODY FORMATION for /biosynthesis $8 eng 980 $x M
Počet záznamov: 1